ARCHIVES

New Understanding of drug Resistance Exciting Revolution

This article is from The Cancer Letter archive.

Vol. 08 No. 36 | September 17, 1982

Download PDF Visit The Full Archive

Related Articles

Kennedy Plans One Year Act Renewal, Followed By Three Year Bill; Hearing Scheduled Feb. 8

February 3, 1978

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Funding Opportunities

October 4, 2002

NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review

May 14, 1993

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005